Exchange: OTC·Updated 10:41 AM EDT

SYRSSyros Pharmaceuticals Inc.

$0.0004
$0.0003
(300.00%)
Today
Reported EarningsOct 31
Mkt Cap$2,683.00
Vol4,364.00

About

Syros Pharmaceuticals, Inc. engages in the development of gene control therapies for cancer and diseases. Its product candidates include SY-1425, SY-2101, and SY-5609. The company was founded by Richard A. Young, Nathanael S. Gray, and James E. Bradner on November 9, 2011 and is headquartered in Cambridge, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Syros Pharmaceuticals Inc.?
What is the 52-week high for Syros Pharmaceuticals Inc.?
What is Syros Pharmaceuticals Inc. stock price today?
What was Syros Pharmaceuticals Inc. stock price yesterday?
What is the 50-day moving average of Syros Pharmaceuticals Inc.?

Advertisement|Remove ads.